Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Seifert

Showing results (21-30 of 239) with videos related to

Pageof 24
Sort By:
Journal of Clinical Microbiology|October 1, 2010
gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3Paul G Higgins, Marlene Lehmann, Hilmar Wisplinghoff, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strainsPaul G Higgins, Hilmar Wisplinghoff, Danuta Stefanik, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2004
Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumanniiPaul G Higgins, Hilmar Wisplinghoff, Danuta Stefanik, et al.
International Journal of Antimicrobial Agents|November 1, 2019
In vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumanniiHarald Seifert, Danuta Stefanik, Melanie Olesky, et al.
Water Research|May 4, 2018
Characterization of Acinetobacter baumannii from water and sludge line of secondary wastewater treatment plantPaul G Higgins, Jasna Hrenovic, Harald Seifert, et al.
Antimicrobial Agents and Chemotherapy|December 9, 2015
The Asp20-to-Asn Substitution in the Response Regulator AdeR Leads to Enhanced Efflux Activity of AdeB in Acinetobacter baumanniiJennifer Nowak, Thamarai Schneiders, Harald Seifert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Vancomycin minimum inhibitory concentration in methicillin-susceptible Staphylococcus aureus and mortality: more than handwaving?Achim J Kaasch, Norma Jung, Gerd Fätkenheuer, et al.
Journal of Global Antimicrobial Resistance|August 10, 2022
Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018)Harald Seifert, Joseph Blondeau, Kai Lucaßen, et al.
Plos One|September 15, 2018
Rapid detection of NDM, KPC and OXA-48 carbapenemases directly from positive blood cultures using a new multiplex immunochromatographic assayAxel Hamprecht, Jörg Janne Vehreschild, Harald Seifert, et al.
Antimicrobial Agents and Chemotherapy|October 6, 2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patientPaul G Higgins, Thamarai Schneiders, Axel Hamprecht, et al.
Pageof 24

Showing results (21-30 of 239) with videos related to

Sort By:
Pageof 24
Journal of Clinical Microbiology|October 1, 2010
gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3Paul G Higgins, Marlene Lehmann, Hilmar Wisplinghoff, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strainsPaul G Higgins, Hilmar Wisplinghoff, Danuta Stefanik, et al.
The Journal of Antimicrobial Chemotherapy|September 10, 2004
Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumanniiPaul G Higgins, Hilmar Wisplinghoff, Danuta Stefanik, et al.
International Journal of Antimicrobial Agents|November 1, 2019
In vitro activity of the novel fluorocycline TP-6076 against carbapenem-resistant Acinetobacter baumanniiHarald Seifert, Danuta Stefanik, Melanie Olesky, et al.
Water Research|May 4, 2018
Characterization of Acinetobacter baumannii from water and sludge line of secondary wastewater treatment plantPaul G Higgins, Jasna Hrenovic, Harald Seifert, et al.
Antimicrobial Agents and Chemotherapy|December 9, 2015
The Asp20-to-Asn Substitution in the Response Regulator AdeR Leads to Enhanced Efflux Activity of AdeB in Acinetobacter baumanniiJennifer Nowak, Thamarai Schneiders, Harald Seifert, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2014
Vancomycin minimum inhibitory concentration in methicillin-susceptible Staphylococcus aureus and mortality: more than handwaving?Achim J Kaasch, Norma Jung, Gerd Fätkenheuer, et al.
Journal of Global Antimicrobial Resistance|August 10, 2022
Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018)Harald Seifert, Joseph Blondeau, Kai Lucaßen, et al.
Plos One|September 15, 2018
Rapid detection of NDM, KPC and OXA-48 carbapenemases directly from positive blood cultures using a new multiplex immunochromatographic assayAxel Hamprecht, Jörg Janne Vehreschild, Harald Seifert, et al.
Antimicrobial Agents and Chemotherapy|October 6, 2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patientPaul G Higgins, Thamarai Schneiders, Axel Hamprecht, et al.
Pageof 24